Top

BMC Geriatrics

Published in:

Open Access 01-12-2022 | Dementia | Research

Predictivity of the comorbidity indices for geriatric syndromes

Authors: Kubra Canaslan, Esra Ates Bulut, Suleyman Emre Kocyigit, Ali Ekrem Aydin, Ahmet Turan Isik

Published in: BMC Geriatrics | Issue 1/2022

Abstract

Background

The aging population and increasing chronic diseases make a tremendous burden on the health care system. The study evaluated the relationship between comorbidity indices and common geriatric syndromes.

Methods

A total of 366 patients who were hospitalized in a university geriatric inpatient service were included in the study. Sociodemographic characteristics, laboratory findings, and comprehensive geriatric assessment(CGA) parameters were recorded. Malnutrition, urinary incontinence, frailty, polypharmacy, falls, orthostatic hypotension, depression, and cognitive performance were evaluated. Comorbidities were ranked using the Charlson Comorbidity Index(CCI), Elixhauser Comorbidity Index(ECM), Geriatric Index of Comorbidity(GIC), and Medicine Comorbidity Index(MCI). Because, the CCI is a valid and reliable tool used in different clinical settings and diseases, patients with CCI score higher than four was accepted as multimorbid. Additionally, the relationship between geriatric syndromes and comorbidity indices was assessed with regression analysis.

Results

Patients’ mean age was 76.2 ± 7.25 years(67.8% female). The age and sex of multimorbid patients according to the CCI were not different compared to others. The multimorbid group had a higher rate of dementia and polypharmacy among geriatric syndromes. All four indices were associated with frailty and polypharmacy(p < 0.05). CCI and ECM scores were related to dementia, polypharmacy, and frailty. Moreover, CCI was also associated with separately slow walking speed and low muscle strength. On the other hand, unlike CCI, ECM was associated with malnutrition.

Conclusions

In the study comparing the four comorbidity indices, it is revealed that none of the indices is sufficient to use alone in geriatric practice. New indices should be developed considering the complexity of the geriatric cases and the limitations of the existing indices.

Population aged 65 and older, percent: UNFPA calculation based on data from United Nations Population Division. 2021. https://www.unfpa.org/data/world-population-dashboard. Accessed 03 Mar 2022.

Growing at a slower pace, world population is expected to reach 9.7 billion in 2050 and could peak at nearly 11 billion around 2100. United Nations World Populations Prospects; 2019. https://www.un.org/sustainabledevelopment/blog/2019/06/growing-at-a-slower-pace-world-population-is-expected-to-reach-9-7-billion-in-2050-and-could-peak-at-nearly-11-billion-around-2100-un-report/#. Accessed 03 Mar 2022.

Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54(7):661–74. https://doi.org/10.1016/s0895-4356(00)00363-2.CrossRefPubMed

van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51(5):367–75. https://doi.org/10.1016/s0895-4356(97)00306-5.CrossRefPubMed

Unutmaz GD, Soysal P, Tuven B, Isik AT. Costs of medication in older patients: before and after comprehensive geriatric assessment. Clin Interv Aging. 2018;13:607–13. https://doi.org/10.2147/cia.s159966.CrossRefPubMedPubMedCentral

Wilson M, Mair A, Dreischulte T, Witham MD. Prescribing to fit the needs of older people–the NHS Scotland Polypharmacy Guidance, 2nd edition. J R Coll Physicians Edinb. 2015;45(2):108–13. https://doi.org/10.4997/jrcpe.2015.204.CrossRefPubMed

Moltó A, Dougados M. Comorbidity indices. Clin Exp Rheumatol. 2014;32(5 Suppl 85):S-131-4.

Giroux Leprieur E, Labrune S, Giraud V, Gendry T, Cobarzan D, Chinet T. Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer. Clin Lung Cancer. 2012;13(5):363–8. https://doi.org/10.1016/j.cllc.2011.11.010.CrossRefPubMed

Dattalo M, DuGoff E, Ronk K, Kennelty K, Gilmore-Bykovskyi A, Kind AJ. Apples and Oranges: Four Definitions of Multiple Chronic Conditions and their Relationship to 30-Day Hospital Readmission. J Am Geriatr Soc. 2017;65(4):712–20. https://doi.org/10.1111/jgs.14539.CrossRefPubMedPubMedCentral

10.

Kansagara D, Englander H, Salanitro A, Kagen D, Theobald C, Freeman M, Kripalani S. Risk prediction models for hospital readmission: a systematic review. JAMA. 2011;306(15):1688–98. https://doi.org/10.1001/jama.2011.1515.CrossRefPubMedPubMedCentral

11.

Rozzini R, Frisoni GB, Ferrucci L, Barbisoni P, Sabatini T, Ranieri P, Guralnik JM, Trabucchi M. Geriatric Index of Comorbidity: validation and comparison with other measures of comorbidity. Age Ageing. 2002;31(4):277–85. https://doi.org/10.1093/ageing/31.4.277.CrossRefPubMed

12.

Pilotto A, Cella A, Pilotto A, Daragjati J, Veronese N, Musacchio C, Mello AM, Logroscino G, Padovani A, Prete C, Panza F. Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions. J Am Med Dir Assoc. 2017;18(2):192.e191–192.e111. https://doi.org/10.1016/j.jamda.2016.11.004.CrossRef

13.

Hall SF. A user’s guide to selecting a comorbidity index for clinical research. J Clin Epidemiol. 2006;59(8):849–55. https://doi.org/10.1016/j.jclinepi.2005.11.013.CrossRefPubMed

14.

Martínez-Velilla N, Cambra-Contin K, Ibáñez-Beroiz B. Comorbidity and prognostic indices do not improve the 5-year mortality prediction of components of comprehensive geriatric assessment in hospitalized older patients. BMC Geriatr. 2014;14:64. https://doi.org/10.1186/1471-2318-14-64.CrossRefPubMedPubMedCentral

15.

Selekler KCB, Uluc S. Power Of Discrimination Of Montreal Cognitive Assessment (MOCA) Scale In Turkish Patients With Mild Cognitive Impairment And Alzheimer’s Disease. Turk J Geriatrics. 2010;13(3):166–71.

16.

Gungen C, Ertan T, Eker E, Yasar R, Engin F. Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population. Turk Psikiyatri Derg. 2002;13(4):273–81.PubMed

17.

Durmaz B, Soysal P, Ellidokuz H, Isik AT. Validity and reliability of geriatric depression scale-15 (short form) in Turkish older adults. Northern Clin Istanbul. 2018;5(3):216–20. https://doi.org/10.14744/nci.2017.85047.CrossRef

18.

Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.CrossRef

19.

Mahoney FI, Barthel DW. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J. 1965;14:61–5.PubMed

20.

Tinetti ME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc. 1986;34(2):119–26.CrossRef

21.

Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. Clin Geriatr Med. 2002;18(4):737–57. https://doi.org/10.1016/s0749-0690(02)00059-9.CrossRefPubMed

22.

van Steenoven I, Aarsland D, Hurtig H, Chen-Plotkin A, Duda JE, Rick J, Chahine LM, Dahodwala N, Trojanowski JQ, Roalf DR, Moberg PJ, Weintraub D. Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson’s disease. Mov Disord. 2014;29(14):1809–15. https://doi.org/10.1002/mds.26062.CrossRefPubMedPubMedCentral

23.

Kocyigit SE, Erken N, Dokuzlar O, Dost Gunay FS, Ates Bulut E, Aydin AE, Soysal P, Isik AT. Postural blood pressure changes in the elderly: orthostatic hypotension and hypertension. Blood Press Monit. 2020. https://doi.org/10.1097/mbp.0000000000000466.CrossRefPubMed

24.

Soysal P, Ates Bulut E, Yavuz I, Isik AT. Decreased Basal Metabolic Rate Can Be an Objective Marker for Sarcopenia and Frailty in Older Males. J Am Med Dir Assoc. 2019;20(1):58–63. https://doi.org/10.1016/j.jamda.2018.07.001.CrossRefPubMed

25.

Dokuzlar O, Koc Okudur S, Soysal P, Kocyigit SE, Yavuz I, Smith L, Ates Bulut E, Isik AT. Factors that Increase Risk of Falling in Older Men according to Four Different Clinical Methods. Exp Aging Res. 2020;46(1):83–92. https://doi.org/10.1080/0361073x.2019.1669284.CrossRefPubMed

26.

Ates Bulut E, Soysal P, Isik AT. Frequency and coincidence of geriatric syndromes according to age groups: single-center experience in Turkey between 2013 and 2017. Clin Interv Aging. 2018;13:1899–905. https://doi.org/10.2147/cia.s180281.CrossRefPubMed

27.

Kocyigit SE, Soysal P, Ates Bulut E, Isik AT. Malnutrition and Malnutrition Risk Can Be Associated with Systolic Orthostatic Hypotension in Older Adults. J Nutr Health Aging. 2018;22(8):928–33. https://doi.org/10.1007/s12603-018-1032-6.CrossRefPubMed

28.

Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82. https://doi.org/10.1093/aje/kwq433.CrossRefPubMed

29.

van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626–33. https://doi.org/10.1097/MLR.0b013e31819432e5.CrossRefPubMed

30.

Narayan SW, Nishtala PS. Development and validation of a Medicines Comorbidity Index for older people. Eur J Clin Pharmacol. 2017;73(12):1665–72. https://doi.org/10.1007/s00228-017-2333-0.CrossRefPubMed

31.

Midão L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213–20. https://doi.org/10.1016/j.archger.2018.06.018.CrossRefPubMed

32.

Cheung JTK, Yu R, Wu Z, Wong SYS, Woo J. Geriatric syndromes, multimorbidity, and disability overlap and increase healthcare use among older Chinese. BMC Geriatr. 2018;18(1):147. https://doi.org/10.1186/s12877-018-0840-1.CrossRefPubMedPubMedCentral

33.

Frenkel WJ, Jongerius EJ, Mandjes-van Uitert MJ, van Munster BC, de Rooij SE. Validation of the Charlson Comorbidity Index in acutely hospitalized elderly adults: a prospective cohort study. J Am Geriatr Soc. 2014;62(2):342–6. https://doi.org/10.1111/jgs.12635.CrossRefPubMed

34.

Chan TC, Luk JK, Chu LW, Chan FH. Validation study of Charlson Comorbidity Index in predicting mortality in Chinese older adults. Geriatr Gerontol Int. 2014;14(2):452–7. https://doi.org/10.1111/ggi.12129.CrossRefPubMed

35.

Buntinx F, Niclaes L, Suetens C, Jans B, Mertens R, Van den Akker M. Evaluation of Charlson’s comorbidity index in elderly living in nursing homes. J Clin Epidemiol. 2002;55(11):1144–7. https://doi.org/10.1016/s0895-4356(02)00485-7.CrossRefPubMed

36.

Ofori-Asenso R, Zomer E, Chin KL, Si S, Markey P, Tacey M, Curtis AJ, Zoungas S, Liew D. Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute Stroke. Int J Environ Res Public Health. 2018;15(11):2532. https://doi.org/10.3390/ijerph15112532.CrossRefPubMedCentral

37.

Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis. 2003;42(1):125–32. https://doi.org/10.1016/s0272-6386(03)00415-3.CrossRefPubMed

38.

Kim CY, Sivasundaram L, LaBelle MW, Trivedi NN, Liu RW, Gillespie RJ. Predicting adverse events, length of stay, and discharge disposition following shoulder arthroplasty: a comparison of the Elixhauser Comorbidity Measure and Charlson Comorbidity Index. J Shoulder Elbow Surg. 2018;27(10):1748–55. https://doi.org/10.1016/j.jse.2018.03.001.CrossRefPubMed

39.

Lieffers JR, Baracos VE, Winget M, Fassbender K. A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer. 2011;117(9):1957–65. https://doi.org/10.1002/cncr.25653.CrossRefPubMed

40.

Ondeck NT, Bohl DD, Bovonratwet P, McLynn RP, Cui JJ, Grauer JN. Discriminative Ability of Elixhauser’s Comorbidity Measure is Superior to Other Comorbidity Scores for Inpatient Adverse Outcomes After Total Hip Arthroplasty. J Arthroplasty. 2018;33(1):250–7. https://doi.org/10.1016/j.arth.2017.08.032.CrossRefPubMed

41.

Velu JF, Haas SD, Van Mourik MS, Koch KT, Vis MM, Henriques JP, Van Den Brink RB, Boekholdt SM, Piek JJ, Bouma BJ, Baan J. Elixhauser Comorbidity Score Is the Best Risk Score in Predicting Survival After Mitraclip Implantation. Structural Heart. 2018;2(1):53–7. https://doi.org/10.1080/24748706.2017.1404172.CrossRef

42.

Gutacker N, Bloor K, Cookson R. Comparing the performance of the Charlson/Deyo and Elixhauser comorbidity measures across five European countries and three conditions. Eur J Pub Health. 2015;25(Suppl 1):15–20. https://doi.org/10.1093/eurpub/cku221.CrossRef

43.

Martínez-Velilla N, Ibáñez-Beroiz B, Cambra-Contin K, Alonso-Renedo J. Is comprehensive geriatric assessment a better 1-year mortality predictor than comorbidity and prognostic indices in hospitalized older adults? J Am Geriatr Soc. 2013;61(10):1821–3. https://doi.org/10.1111/jgs.12488.CrossRefPubMed

44.

Wyka J, Biernat J, Mikołajczak J, Piotrowska E. Assessment of dietary intake and nutritional status (MNA) in Polish free-living elderly people from rural environments. Arch Gerontol Geriatr. 2012;54(1):44–9. https://doi.org/10.1016/j.archger.2011.02.001.CrossRefPubMed

45.

Chen CT, Tung HH, Chen YC, Lee HF, Wang CJ, Lin WH. Depressive symptoms and nutritional status in the frail older adults. Arch Gerontol Geriatr. 2019;83:96–100. https://doi.org/10.1016/j.archger.2019.03.023.CrossRefPubMed

46.

Chang J, Hou WW, Wang YF, Sun QM. Main Risk Factors Related to Activities of Daily Living in Non-Dialysis Patients with Chronic Kidney Disease Stage 3–5: A Case-Control Study. Clin Interv Aging. 2020;15:609–18. https://doi.org/10.2147/cia.s249137.CrossRefPubMedPubMedCentral

47.

Silay K, Yalcin A, Akinci S, Gursoy FG, Sener Dede D. Charlson Comorbidity Index, inappropriate medication use and cognitive impairment : Bermuda Triangle. Wien Klin Wochenschr. 2017;129(21–22):799–804. https://doi.org/10.1007/s00508-017-1253-4.CrossRefPubMed

48.

Librero J, Peiró S, Ordiñana R. Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. J Clin Epidemiol. 1999;52(3):171–9. https://doi.org/10.1016/s0895-4356(98)00160-7.CrossRefPubMed

49.

Liu J, Larson E, Hessels A, Cohen B, Zachariah P, Caplan D, Shang J. Comparison of Measures to Predict Mortality and Length of Stay in Hospitalized Patients. Nurs Res. 2019;68(3):200–9. https://doi.org/10.1097/nnr.0000000000000350.CrossRefPubMedPubMedCentral

50.

Mahmoud MM, Abdel-Fadeel NAM, Hassan M, Taha M, El-Sherbiny A, Eldin AMS, Khafagy AT. Geriatric depression: prevalence, risk factors, and relationship to physical illnesses in a sample of medical clinic outpatients. Middle East Current Psychiatry. 2016;23(9S):98.

Title: Predictivity of the comorbidity indices for geriatric syndromes
Authors: Kubra Canaslan
Esra Ates Bulut
Suleyman Emre Kocyigit
Ali Ekrem Aydin
Ahmet Turan Isik
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Dementia
Dementia
Geriatric Assessment
Published in: BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI: https://doi.org/10.1186/s12877-022-03066-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Correction: Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis

TOMM40 genetic variants associated with healthy aging and longevity: a systematic review

Family caregiver quality of life and the care provided to older people living with dementia: qualitative analyses of caregiver interviews

The effect of subjective social status on health-related quality of life decline in urban Chinese older adults: a four-year longitudinal study from Hong Kong

Prevalence of oral anticoagulant use among people with and without Alzheimer’s disease

Community-based mental health and well-being interventions for older adults in low- and middle-income countries: a systematic review and meta-analysis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials